PGP and myopathy: Thus, modelling of P-gp-mediated transport processes in ATS PBPK is important to better characterize potential DDIs at this level not only as a perpetrator, but also as a victim drug, to avoid high exposures that could lead to the development of adverse events such as myopathies.